Skip to content

Medical-device intelligence

PCG: 21-Hydroxylase Antibody (21-Ohab)

FDA product code PCG: 21-Hydroxylase Antibody (21-Ohab). View classification details, related manufacturers, 510(k) clearances, and recall records.

FDA classification ↗

Classification details

Product code
PCG
FDA device name
21-Hydroxylase Antibody (21-Ohab)
Device class
2
Regulation number
866.5660
Medical specialty
Immunology
Review panel
IM

FDA definition

For semi-quantitative determination of antibodies to steroid 21-hydroxylase (21-OH) in human serum. The assay may be useful as an aid in the diagnosis of autoimmune adrenal disease, whether expressed as autoimmune Addison's disease (isolated) or Addison's disease as part of more complex autoimmune polyglandular syndrome (APS), type I or II. The assay result is to be used in conjunction with other clinical and laboratory findings and is not a substitute for functional testing required to diagnose adrenal insufficiency.
Explore immunology records →
A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.

Record activity in this scope

2 clearance records and 0 recall records in the covered releases, across 2 source company names and 1 product codes. Dated history runs from Dec 20, 2012 to Nov 23, 2018.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

Code and FDA device nameClearancesRecalls
PCG · 21-Hydroxylase Antibody (21-Ohab)20

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

2 matching records
Device / recordCompany in FDA recordSourceSource date
Steroid 21-Hydroxylase Antibody (21-OHAb) ELISA KitK180607 · PCGKronus, Inc.510(k)Nov 23, 2018FDA decision date
STEROID 21-HYDROXYLASE ANTIBODY (21-OHAB) RIA ASSAY KITK121046 · PCGKronus Market Development Associates, Inc.510(k)Dec 20, 2012FDA decision date

Manufacturers in these records

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 21, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗